Piramal Pharma Solutions Executive and Leadership Team

Bhargava Chari, the Chief Executive Officer at Piramal Pharma Solutions, directs the overarching corporate strategy and long-term vision for the organization. Chari oversees the integration of global CDMO operations, ensuring that the company maintains a competitive edge in drug discovery and commercial API supply. By aligning internal resources with the needs of innovator and generic pharmaceutical companies, the Chief Executive Officer drives sustainable growth across international markets. This leadership role involves constant collaboration with the Board to optimize the portfolio of services, including specialized antibody-drug conjugations and sterile fill/finish capabilities. Through rigorous oversight of the global network, Bhargava Chari ensures that the organization meets complex regulatory standards while scaling production capacity. Ultimately, Chari secures the company's position as a preferred partner for pharmaceutical development, fostering innovation and operational excellence across the entire drug life cycle.

Sourabh Lodhi, the Co-Chief Executive Officer at Piramal Pharma Solutions, manages the expansion of biologics and advanced therapeutic services. Lodhi focuses on the strategic development of vaccines, gene therapies, and monoclonal antibodies, leveraging the company's investment in Yapan Bio to broaden the service footprint. By coordinating cross-functional teams, the Co-Chief Executive Officer ensures that specialized peptide products and potent solid oral drug manufacturing remain at the forefront of the industry. This leadership role requires deep engagement with global market trends to identify new opportunities for technological advancement. Sourabh Lodhi directs the implementation of high-growth initiatives that enhance the company's ability to support complex clinical trial supplies. Through meticulous planning and execution, Lodhi strengthens the organization's capacity to deliver high-value solutions, ensuring that the business remains agile and responsive to the evolving requirements of global healthcare partners.

Herve Berdou, the Chief Operating Officer at Piramal Pharma Solutions, manages the daily operational efficiency of the global manufacturing network. Berdou oversees the production of APIs and finished dosage forms, ensuring that all facilities across North America, Europe, and Asia adhere to strict quality and safety protocols. By optimizing supply chain logistics and manufacturing workflows, the Chief Operating Officer drives productivity and reduces time-to-market for client projects. This leadership role involves close coordination with site managers to maintain consistent performance standards across diverse technological platforms. Herve Berdou implements lean manufacturing principles to maximize output while maintaining the high precision required for potent drug production. Through constant monitoring of operational metrics, Berdou ensures that the company delivers reliable, high-quality results for global clients, effectively supporting the organization's mission to provide comprehensive, end-to-end development and manufacturing solutions.

Rubina Malik, the Chief Technology Officer at Piramal Pharma Solutions, architects the technical roadmap for pharmaceutical development and process innovation. Malik oversees the integration of cutting-edge technologies, including advanced analytical methods and specialized manufacturing processes for highly potent compounds. By directing research and development initiatives, the Chief Technology Officer ensures that the company remains at the leading edge of drug discovery and process engineering. This leadership role involves evaluating emerging scientific trends to enhance the organization's service offerings in biologics and complex chemistry. Rubina Malik collaborates with technical teams to implement robust digital and scientific infrastructure, facilitating seamless transitions from clinical development to commercial scale. Through the continuous improvement of technical capabilities, Malik drives the innovation necessary to solve complex formulation challenges, ultimately ensuring that the company provides superior value to partners through scientific excellence and technological sophistication.